TQD-3606

N/A

Report date: 2025/03/26 16:55:26

Base Information

Drug NameTQD-3606
Drug Alias NameTQD-3606TQD3606
ClassificationSmall molecules
Mechanisms of ActionBeta Lactamase inhibitorsBacterial penicillin-binding protein modulators
TargetsBeta LactamaseBacterial penicillin-binding protein
Therapy Area/IndicationsSusceptible anaerobic bacteria infectionGram-Positive Bacterial InfectionsGram-Negative Bacterial Infections +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSusceptible anaerobic bacteria infectionGram-Positive Bacterial InfectionsGram-Negative Bacterial Infections +[5] 
Inactive IndicationsInfections

Other Information

ATC CodeN/A
Related LinksN/A